In this study, we want to learn more about the safety and effectiveness of a drug called JANX008 in people with advanced or metastatic cancer. This is a study for people with non-small cell lung cancer, squamous cell carcinoma of the head and neck, colorectal cancer, or renal cell carcinoma.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Jared Weiss
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Phase 1 Trials (all cancers))
23-1044
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
